Access cutting-edge kidney cancer treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access kidney cancer specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney cancer treatment provided free
The researchers are doing this study to find out whether the combination of abemaciclib and cabozantinib is a safe and effective treatment for people with metastatic clear cell renal cell carcinoma (ccRCC) and translocation-associated renal cell cancer (tRCC). The researchers will test different doses of the study drugs to find the highest doses that cause few or mild side effects in participants.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this kidney cancer clinical trial in New York, NY
If you're searching for kidney cancer treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.